Zobrazeno 1 - 10
of 67
pro vyhledávání: '"A. Jonebring"'
Autor:
T. BONGOLAN, T. Chow, J. Whiteley, B. Larsen, L. Mazilescu, M. Hamar, A. Jonebring, R. Hicks, M. Selzner, I. Rogers
Publikováno v:
Kidney International Reports, Vol 6, Iss 4, Pp S206- (2021)
Externí odkaz:
https://doaj.org/article/e65f8e9cd96c4d8c91f3125ee3aa8028
Autor:
Boreström, Cecilia, Jonebring, Anna, Guo, Jing, Palmgren, Henrik, Cederblad, Linda, Forslöw, Anna, Svensson, Anna, Söderberg, Magnus, Reznichenko, Anna, Nyström, Jenny, Patrakka, Jaakko, Hicks, Ryan, Maresca, Marcello, Valastro, Barbara, Collén, Anna
Publikováno v:
In Kidney International December 2018 94(6):1099-1110
Autor:
Paul A. De Sousa, Rachel Steeg, Elisabeth Wachter, Kevin Bruce, Jason King, Marieke Hoeve, Shalinee Khadun, George McConnachie, Julie Holder, Andreas Kurtz, Stefanie Seltmann, Johannes Dewender, Sascha Reimann, Glyn Stacey, Orla O'Shea, Charlotte Chapman, Lyn Healy, Heiko Zimmermann, Bryan Bolton, Trisha Rawat, Isobel Atkin, Anna Veiga, Bernd Kuebler, Blanca Miranda Serano, Tomo Saric, Jürgen Hescheler, Oliver Brüstle, Michael Peitz, Cornelia Thiele, Niels Geijsen, Bjørn Holst, Christian Clausen, Majlinda Lako, Lyle Armstrong, Shailesh K. Gupta, Alexander J. Kvist, Ryan Hicks, Anna Jonebring, Gabriella Brolén, Andreas Ebneth, Alfredo Cabrera-Socorro, Patrik Foerch, Martine Geraerts, Tina C. Stummann, Shawn Harmon, Carol George, Ian Streeter, Laura Clarke, Helen Parkinson, Peter W. Harrison, Adam Faulconbridge, Luca Cherubin, Tony Burdett, Cesar Trigueros, Minal J Patel, Christa Lucas, Barry Hardy, Rok Predan, Joh Dokler, Maja Brajnik, Oliver Keminer, Ole Pless, Philip Gribbon, Carsten Claussen, Annette Ringwald, Beate Kreisel, Aidan Courtney, Timothy E. Allsopp
Publikováno v:
Stem Cell Research, Vol 20, Iss C, Pp 105-114 (2017)
A fast track “Hot Start” process was implemented to launch the European Bank for Induced Pluripotent Stem Cells (EBiSC) to provide early release of a range of established control and disease linked human induced pluripotent stem cell (hiPSC) line
Externí odkaz:
https://doaj.org/article/d5c03414c1b04475bf195ed59dedab4f
Autor:
Shamshirgaran, Yasaman1, Jonebring, Anna1, Svensson, Anna1, Leefa, Isabelle1, Bohlooly-Y, Mohammad1, Firth, Mike2, Woollard, Kevin J.3, Hofherr, Alexis4, Rogers, Ian M.5,6,7,8, Hicks, Ryan9 Ryan.Hicks@AstraZeneca.com
Publikováno v:
Scientific Reports. 8/16/2021, Vol. 11 Issue 1, p1-9. 9p.
Autor:
Tonya Bongolan, Jennifer Whiteley, Jorge Castillo-Prado, Amanda Fantin, Brett Larsen, Cassandra J. Wong, Laura Mazilescu, Masataka Kawamura, Peter Urbanellis, Anna Jonebring, Eric Salter, Graham Collingridge, Rebecca Gladdy, Ryan Hicks, Anne-Claude Gingras, Markus Selzner, Ian M. Rogers
Publikováno v:
Biomaterials science. 10(11)
When decellularizing kidneys, it is important to maintain the integrity of the acellular extracellular matrix (ECM), including associated adhesion proteins and growth factors that allow recellularized cells to adhere and migrate according to ECM spec
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sofia Martinsson, Mei Ding, Alan Sabirsh, Henrik Andersson, Alleyn T. Plowright, Qing-Dong Wang, Anna Jonebring, Lauren Drowley
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-14 (2020)
Scientific Reports
Scientific Reports
Cardiac progenitor cells (CPCs), capable of differentiating into multiple cardiac cell types including cardiomyocytes (CMs), endothelial cells, and smooth muscle cells, are promising candidates for cardiac repair/regeneration. In vitro model systems
Autor:
Anna Svensson, Yasaman Shamshirgaran, Ian M. Rogers, Mohammad Bohlooly-Y, Isabelle Leefa, Anna Jonebring, Ryan Hicks, Mike Firth, Kevin J. Woollard, Alexis Hofherr
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Recent advances in induced pluripotent stem cells (iPSCs), genome editing technologies and 3D organoid model systems highlight opportunities to develop new in vitro human disease models to serve drug discovery programs. An ideal disease model would a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Oliver Brüstle, Annette Ringwald, Christian Clausen, Charlotte Chapman, Glyn Stacey, Alexander J. Kvist, Marieke A. Hoeve, Shailesh Kumar Gupta, Blanca Miranda Serano, Minal Patel, Gabriella Brolén, Tomo Saric, George McConnachie, Cornelia Thiele, Julie Holder, Trisha Rawat, Tina C. Stummann, Joh Dokler, Maja Brajnik, Bryan Bolton, Lyle Armstrong, Bernd Kuebler, Alfredo Cabrera-Socorro, Isobel Atkin, Adam Faulconbridge, Christa Lucas, Jason A. King, Johannes Dewender, Ian Streeter, Rok Predan, Majlinda Lako, Lyn Healy, Bjørn Holst, Martine Geraerts, Luca Cherubin, Carsten Claussen, Heiko Zimmermann, Timothy E Allsopp, Orla O'Shea, Peter W. Harrison, K. Bruce, Niels Geijsen, Michael Peitz, Tony Burdett, Paul A. De Sousa, Ole Pless, Elisabeth Wachter, Anna Veiga, A. Courtney, Laura Clarke, Helen Parkinson, Cesar Trigueros, Anna Jonebring, Shalinee Khadun, Rachel Steeg, Patrik Foerch, Sascha Reimann, Ryan Hicks, Carol George, Andreas Ebneth, Oliver Keminer, Philip Gribbon, Barry Hardy, Stefanie Seltmann, Andreas Kurtz, Shawn Harmon, Jürgen Hescheler, Beate Kreisel
Publikováno v:
Stem Cell Research, Vol 20, Iss C, Pp 105-114 (2017)
De Sousa, P A, Steeg, R, Wachter, E, Bruce, K, King, J, Hoeve, M, Khadun, S, Mcconnachie, G, Holder, J, Kurtz, A, Seltmann, S, Dewender, J, Reimann, S, Stacey, G, O'shea, O, Chapman, C, Healy, L, Zimmermann, H, Bolton, B, Rawat, T, Atkin, I, Veiga, A, Kuebler, B, Serano, B M, Saric, T, Hescheler, J, Brüstle, O, Peitz, M, Thiele, C, Geijsen, N, Holst, B, Clausen, C, Lako, M, Armstrong, L, Gupta, S K, Kvist, A J, Hicks, R, Jonebring, A, Brolén, G, Ebneth, A, Cabrera-socorro, A, Foerch, P, Geraerts, M, Stummann, T C, Harmon, S, George, C, Streeter, I, Clarke, L, Parkinson, H, Harrison, P W, Faulconbridge, A, Cherubin, L, Burdett, T, Trigueros, C, Patel, M J, Lucas, C, Hardy, B, Predan, R, Dokler, J, Brajnik, M, Keminer, O, Pless, O, Gribbon, P, Claussen, C, Ringwald, A, Kreisel, B, Courtney, A & Allsopp, T E 2017, ' Rapid establishment of the European Bank for induced Pluripotent Stem Cells (EBiSC) : The Hot Start experience ', Stem Cell Research, vol. 20, pp. 105-114 . https://doi.org/10.1016/j.scr.2017.03.002
Stem Cell Research, 20, 105. Elsevier
Stem Cell Research, 20, 105
Stem Cell Research, 20, 105-114
NARCIS
BASE (Open Access Aggregator)
UnpayWall
DOAJ-Articles
ORCID
Microsoft Academic Graph
Stem Cell Research, 20, 105-114. Elsevier B.V.
Stem Cell Research
De Sousa, P A, Steeg, R, Wachter, E, Bruce, K, King, J, Hoeve, M, Khadun, S, Mcconnachie, G, Holder, J, Kurtz, A, Seltmann, S, Dewender, J, Reimann, S, Stacey, G, O'shea, O, Chapman, C, Healy, L, Zimmermann, H, Bolton, B, Rawat, T, Atkin, I, Veiga, A, Kuebler, B, Serano, B M, Saric, T, Hescheler, J, Brüstle, O, Peitz, M, Thiele, C, Geijsen, N, Holst, B, Clausen, C, Lako, M, Armstrong, L, Gupta, S K, Kvist, A J, Hicks, R, Jonebring, A, Brolén, G, Ebneth, A, Cabrera-socorro, A, Foerch, P, Geraerts, M, Stummann, T C, Harmon, S, George, C, Streeter, I, Clarke, L, Parkinson, H, Harrison, P W, Faulconbridge, A, Cherubin, L, Burdett, T, Trigueros, C, Patel, M J, Lucas, C, Hardy, B, Predan, R, Dokler, J, Brajnik, M, Keminer, O, Pless, O, Gribbon, P, Claussen, C, Ringwald, A, Kreisel, B, Courtney, A & Allsopp, T E 2017, ' Rapid establishment of the European Bank for induced Pluripotent Stem Cells (EBiSC) : The Hot Start experience ', Stem Cell Research, vol. 20, pp. 105-114 . https://doi.org/10.1016/j.scr.2017.03.002
Stem Cell Research, 20, 105. Elsevier
Stem Cell Research, 20, 105
Stem Cell Research, 20, 105-114
NARCIS
BASE (Open Access Aggregator)
UnpayWall
DOAJ-Articles
ORCID
Microsoft Academic Graph
Stem Cell Research, 20, 105-114. Elsevier B.V.
Stem Cell Research
A fast track “Hot Start” process was implemented to launch the European Bank for Induced Pluripotent Stem Cells (EBiSC) to provide early release of a range of established control and disease linked human induced pluripotent stem cell (hiPSC) line